*ViiV Healthcare employees receive 100% of GSK's Total Rewards and Benefits
ViiV Healthcare is an independent, global specialist HIV company dedicated to delivering innovative new options for the care and treatment of people living with HIV/AIDS. HIV presents a serious global challenge. At ViiV Healthcare we are using our commitment, expertise and passion to help meet this challenge by dedicating ourselves to delivering advances in treatment and care for people living with HIV.
ViiV Healthcare was created in 2009 with an ambition of launching a “best in class” integrase inhibitor, maximizing value of existing HIV products and allowing acute company focus on developing initiatives, compounds and access that would advance the care and treatment of HIV.
Since that time, the successful launches of 4 Dolutegravir-based products have increased internal and external stakeholder demand for Medical Affairs support to ensure appropriate use of and access to our products as well as to serve as an educational resource.
In addition, there is consistent progression of research on ViiV Healthcare compounds to address data gaps that exist for Dolutegravir and our newer compounds, which includes advancing cabotegravir clinical development for both HIV treatment and prevention. The NA Medical Affairs team continues to play a significant role in ensuring capable sites are identified and selected, researchers are properly educated and informed, and studies progress in timely manner.
Additionally, HIV therapy is now being actively managed by many players and this has elevated the need to provide HIV clinical and research information to formulary decision makers and payers groups, increasing demand for Medical Affairs partnership.
There is a critical need now to enhance the medical and scientific leadership capability to effectively and credibly exchange high quality medical and scientific information about ViiV products and the disease area with our customers. Without this, we will not be able to deliver on our promises to patients or to our shareholders and become industry-leading.
The role of Director Brand Payer Marketing - Injectables is responsible for leading the strategic development of robust payer value propositions and the tactical execution of customer engagement tools for ViiV’s near-term launches of the Cabotegravir-based HIV Treatment and Prevention (PrEP) long-acting injectable products. This is an integral role within the US Market Access function and involves significant levels of matrix management to appropriately influence stakeholders and manage priorities. This includes working with cross-functional colleagues to assess the external environment, derive customer insights, and develop the tailored strategies & tactics that align to customer needs and achieve access goals across payer customer segments amid an ever-changing US payer landscape. The role also partners with US Health Outcomes to identify and align on evidence generation plans that will support payer data needs.
This role will provide YOU the opportunity to lead key activities to progress YOUR career, these responsibilities include some of the following…
Design, build and maintain integrated payer value propositions for target segment population-based decision makers
Lead initiatives to identify insights and understand the clinical, economic and societal value elements that align to payer customer formulary decision criteria and motivations
Develop and implement payer promotional strategies, resources, and tools that support strategic account engagement and clearly communicate the value of the Cabotegravir-based HIV Treatment and Prevention (PrEP) long-acting injectable products
Collaborate within and beyond market access to bring stakeholders along, simplify the complex and elevate organizational payer acumen and understanding
Partner with strategic pricing, contracting and reimbursement to optimize understanding of the customer landscape and integrate price into the overall value narrative
Support training of all customer-facing teams (payer field team, field sales, FRMs) on market access topics for the Cabotegravir product line
Transparently communicate about the access landscape and support the cross-functional triaging of access and reimbursement issues
Partner with US Health Outcomes on evidence generation planning to support payer customer needs and overall brand value positioning
Supervise, coach, develop and evaluate direct reports including normal and customary supervisory responsibilities such as budget management, performance evaluation, coaching, development, etc.
Superior interpersonal skills with ability to lead, influence, and gain alignment cross-functionally (internal stakeholder groups include Brand Marketing, Payer Field Team, Sales, Medical, Legal, Regulatory, HEOR, etc.)
Set priorities and provides clear recommendations in complex and ambiguous circumstances
Lead and manage agency relationships
Ensure compliance with all applicable laws, regulations and regulatory guidelines governing commercial and scientific interactions with healthcare professionals, payers, advocacy and other business partners
We are looking for professionals with these required skills to achieve our goals:
Bachelor’s degree or equivalent in Business, Marketing, or related discipline
5+ years of US-based pharmaceutical industry experience in managed markets, marketing and/or related commercial roles
Knowledge and understanding of commercial and public payer customers (i.e. PBMs, MCO, employer, Medicaid, Medicare) and the complex dynamics affecting the payer including industry trends, payer and channel economics, and public policy/ government regulations
If you have the following characteristics, it would be a plus:
Graduate to Post Graduate Degree level (e.g. master, PhD) or equivalent experience
Prior market access experience with provider-administered injectables or specialty products
Experience working on a product launch, particularly with specialty products and/or preventative medicines
Experience in or understanding of the HIV therapeutic area
Strong business acumen and experience developing payer and segment specific marketing insights
Strong B2B strategic thinking skills and demonstrated ability to translate customer (payer), competitive, and environmental insights into commercial strategy and tactical plans
Excellent communication skills (written, verbal & presentation) with the ability to succinctly communicate complex information and present effectively to large groups and senior leaders
Strong interpersonal skills required with proven ability to develop and maintain trusted relationships, work well in cross-functional teams, and to lead & influence across matrixed organizations (including influencing without authority)
Demonstrated learning agility with a high level of curiosity and motivation to manage complexity and solve problems in ambiguous environments
Proven ability to translate strategic direction into action plans, manage competing priorities, and foster organizational alignment under tight timelines
Experience working with and managing external agencies
Knowledge and understanding of compliance and regulatory environment including programs designed to educate payers on drug safety and appropriate use (FDAMA 114, pre-approval information exchange…)
Experience managing, motivating and coaching direct reports
Employer will assist with relocation costs.
Internal Number: 264364
About ViiV Healthcare (GSK)
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to being a trusted partner for all people living with and affected by HIV. Our aim is to think, act, and connect differently through a focus on education on and treatment for HIV. We go to extraordinary lengths to deliver the sorts of breakthroughs, both in treatments, care solutions and communities, that really count. We go beyond the boundaries of medicine by taking a holistic approach to HIV through developing and supporting sustainable community programs and improving access to care. We are fully committed to push through every challenge until HIV/AIDS is eradicated. ViiV has played a significant part in delivering breakthroughs that have turned HIV into a manageable health condition. We offer the largest portfolio of HIV medicines available anywhere, and we continue our work to cater for the widest possible range of needs in response to the HIV epidemic.
We are aware of how much is at stake for those affected by HIV and we show up every day 1...00% committed to the patients. Our work culture is fast-paced, diverse, inclusive, competitive, and caring. But ViiV isn’t just somewhere to work – it’s a place to belong, an invitation to bring your very best, and a team full of impact-driven team members who are hungry to make a difference.
While we have been improving lives of HIV patients for 30 years, this is an especially exciting time to be at ViiV, as we evaluate novel approaches to treatment and prevention that could further reduce the impact of HIV on individuals and communities.
ViiV Healthcare was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi.
BACK TO TOP
EACA Job Bank is Just One of the Benefits.
Discover what else EACA has to offer!
The job you are trying to reach from was originally posted at EACA Job Bank.